20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Overview of attention for article published in New England Journal of Medicine, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 304 news stories from 162 outlets.

Abstract Background The metabolism of cancer cells generally differs from that of normal cells.

Because of the variety of treatment options available for patients with low-risk breast cancer, physicians must consider each…

ロバート・W・ムター医学博士のプレゼンテーションによると、低リスク乳がん患者には利用可能な治療選択肢が多数あるため、臨床医は適切な治療コースを選択する際に各患者の固有の臨床プロフィールと治療目標を考慮する必要がある。放射線腫瘍学サミット: ACRO…

En raison de la multitude d’options thérapeutiques disponibles pour les patientes atteintes d’un cancer du sein à faible risque…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 300 additional news stories.